INVESCO NASDAQ BIOTECH UCITS ETF ACC - USD |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 42.22 USD | -0.58% |
|
-3.73% | -7.36% |
| Current month | -8.23% | ||
| 1 month | -6.53% |
Investment objective
The Invesco NASDAQ Biotech UCITS ETF Acc aims to provide the performance of the NASDAQ Biotechnology Index, after fees. The index comprises biotechnology and pharmaceuticals companies (as defined by ICB) listed on the NASDAQ Stock Market. Stocks are filtered to meet minimum market capitalisation and liquidity requirements. They are then weighted by modified market capitalisation: the largest five constituents are capped at 8%; the remaining constituents are capped at 4%. The index is rebalanced quarterly and reviewed annually in December.
More news
In partnership with
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-18 | 42.22 | -0.58% | 64,813 |
| 24-04-17 | 42.46 | -0.90% | 6,150 |
| 24-04-16 | 42.85 | -1.02% | 44,113 |
| 24-04-15 | 43.29 | -0.87% | 14,324 |
| 24-04-12 | 43.67 | -0.78% | 8,553 |
Other stock markets
Delayed Quote London S.E.
Last update April 18, 2024 at 11:35 am EDT
More quotesETF Ratings
 |
Description
| IE00BQ70R696 | |
|---|---|
| Total Expense Ratio | 0.40% |
| Asset Class | |
| Sector | |
| Size | |
| Currency | |
| Provider | |
| Underlying | NASDAQ Biotechnology Total Return Index - USD |
Features and characteristics
| Jurisdiction | |
| Replication Method | |
| Replication Model | |
| Date of creation |
2014-11-06
|
| Dividend Policy | |
| Geographical Focus |
AuM evolution ( 2024-03-26 )
| AuM (EUR) | 595 M€ |
|---|---|
| AuM 1M | 606 M€ |
| AuM 3 months | 525 M€ |
| AuM 6 months | 527 M€ |
| AuM 12 months | 546 M€ |
- Stock Market
- ETF
- SBIO ETF
